Literature DB >> 1424742

Production of interleukin-6 by human retinal pigment epithelium in vitro and its regulation by other cytokines.

M T Benson1, L Shepherd, R C Rees, I G Rennie.   

Abstract

Interleukin-6 (IL-6) is a pleiotropic cytokine which produces uveitis if administered intraocularly. It has been demonstrated in the aqueous of patients with various uveitis entities. We have investigated the ability of human retinal pigment epithelium (RPE) to produce IL-6 in vitro, both unstimulated, and in the presence of interleukin-1 (IL-1), tumor necrosis factor alpha (TNF), interferon (IFN) gamma, and lipopolysaccharide (LPS). Five human RPE cell lines were cultured over a 6-day period, both unstimulated and in the presence of these cyokines. IL-6 in the supernatants was measured using an ELISA assay. Unstimulated RPE produced small amounts of IL-6. IL-1 at 100 or 10 U/ml markedly upregulated IL-6 production, and TNF at 1000, 100 or 10 U/ml did so to a lesser extent. Neither IFN gamma or LPS alone increased IL-6 expression, but together gave significant upregulation. Thus human RPE can produce IL-6 and may be the source of this cytokine in ocular inflammatory states.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1424742     DOI: 10.3109/02713689208999529

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  16 in total

1.  The dangers of sublethal carvacrol exposure: increases in virulence of Bacillus cereus during endophthalmitis.

Authors:  Niloofar Rajabli; Lauren Williamson; Pierre S Nimmer; Marie Kelly-Worden; Jill S Bange; Yenling Ho; John L McKillip
Journal:  Int J Biochem Mol Biol       Date:  2018-10-08

2.  Myeloid suppressor cells induced by retinal pigment epithelial cells inhibit autoreactive T-cell responses that lead to experimental autoimmune uveitis.

Authors:  Zhidan Tu; Yan Li; Dawn Smith; Catherine Doller; Sunao Sugita; Chi-Chao Chan; Shiguang Qian; John Fung; Rachel R Caspi; Lina Lu; Feng Lin
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-23       Impact factor: 4.799

Review 3.  Involvement of Müller glial cells in epiretinal membrane formation.

Authors:  Andreas Bringmann; Peter Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-05       Impact factor: 3.117

4.  Retinal pigment epithelial cells: autocrine and paracrine stimulation of extracellular matrix contraction.

Authors:  S Grisanti; P Esser; U Schraermeyer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-09       Impact factor: 3.117

5.  Polarized secretion of IL-6 and IL-8 by human retinal pigment epithelial cells.

Authors:  G M Holtkamp; M Van Rossem; A F de Vos; B Willekens; R Peek; A Kijlstra
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

6.  Calf melanin immunomodulates RPE cell attachment to extracellular matrix protein.

Authors:  Sally M Yacout; Sherine F Elsawa; Elizabeth R Gaillard
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-07-31       Impact factor: 3.117

Review 7.  Cytokines in posterior uveitis: an update.

Authors:  V K Singh; G Rai
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

8.  Analysis of the secretion pattern of monocyte chemotactic protein-1 (MCP-1) and transforming growth factor-beta 2 (TGF-beta2) by human retinal pigment epithelial cells.

Authors:  G M Holtkamp; A F De Vos; R Peek; A Kijlsta
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

9.  Attenuation of EMT in RPE cells and subretinal fibrosis by an RAR-γ agonist.

Authors:  Kazuhiro Kimura; Tomoko Orita; Yang Liu; Yang Yang; Kazuhiro Tokuda; Taishi Kurakazu; Takeshi Noda; Ryoji Yanai; Naoyuki Morishige; Atsunobu Takeda; Tatsuro Ishibashi; Koh-Hei Sonoda
Journal:  J Mol Med (Berl)       Date:  2015-05-08       Impact factor: 4.599

10.  The pro-inflammatory role of high-mobility group box 1 protein (HMGB-1) in photoreceptors and retinal explants exposed to elevated pressure.

Authors:  Michael R R Böhm; Maurice Schallenberg; Katrin Brockhaus; Harutyun Melkonyan; Solon Thanos
Journal:  Lab Invest       Date:  2016-01-18       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.